Cannara Biotech Inc. to Announce Fiscal Q4 2025 and Fiscal Year 2025 Financial Results on November 24, 2025 and Provides Board Update

Executive Summary

• Cannara Biotech announced that its fiscal Q4 and full‑year 2025 financial results will be released on Monday, Nov 24 2025 at 7:00 a.m. ET.
• CEO Zohar Krivorot and CFO Nicholas Sosiak will host an earnings webcast at 11:00 a.m. ET on the same day, with a live Q&A session.
• The company announced the passing of long‑time board member Jack M. Kay, highlighting his extensive leadership background and expressing condolences to his family.

Key Details

• Earnings Release Timing: Fiscal fourth quarter and fiscal year ended August 31 2025 results to be released 7:00 a.m. ET, Nov 24 2025.
• Webcast Information: Hosted by CEO Zohar Krivorot and CFO Nicholas Sosiak at 11:00 a.m. ET; registration link provided; archived after the event.
• Investor Interaction: Investors may submit questions in advance to [email protected]; live questions accepted, with priority to emailed submissions.
• Board Update – Passing of Jack M. Kay:
• Board member since 2019; over five decades of pharmaceutical and sales executive experience.
• Former CEO, COO, President, Vice Chairman of Apotex Inc.; held senior roles at Helix Biopharma Corp., Cangene Corp., Barr Pharmaceuticals Inc.
• Community leadership includes Chairmanship of Humber River Regional Hospital (Toronto).
• Company extends condolences to his family and thanks him for his service.

Notable Quotes

No direct quotes were included in the release.